Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.
Use this NTLA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NTLA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NTLA SEC filings page. Lician reads the product cache first so this HTML stays unique to Intellia Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NTLA income, balance, and cash tables.